Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial

The Diabetes Control and Complications Trial established that a stimulated C-peptide concentration ≥0.2 nmol/L at study entry among subjects with up to a 5-year diabetes duration is associated with favorable metabolic and clinical outcomes over the subsequent 7 years of follow-up. Herein we further...

Descripción completa

Detalles Bibliográficos
Autores principales: Lachin, John M., McGee, Paula, Palmer, Jerry P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2014
Materias:
Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900540/
https://www.ncbi.nlm.nih.gov/pubmed/24089509
http://dx.doi.org/10.2337/db13-0881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900540/
https://www.ncbi.nlm.nih.gov/pubmed/24089509
http://dx.doi.org/10.2337/db13-0881

Ejemplares similares